Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries

Learn more

White Paper: Market access for medical devices in Europe: England, France, Germany, Italy and Spain

Get insights from MTRC White Papers to advance your understanding of European market access for medical devices

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The application period for the 2026 NUB innovation funding is open in Germany

On September 1, 2025, the Institute for Hospital Remuneration Systems (INeK) announced the start of the application process according to §6 (2) KHEntgG (New Examination and Treatment Methods, NUB) for 2026. 

The scope of the NUB program includes innovative technologies, causing significant extra costs that are not covered by existing DRG tariffs. The selection of technologies is made by the InEK according to the inclusion criteria. A positive decision by InEK does not indicate that reimbursement is provided. Rather, it gives applying hospitals permission to enter into negotiations with local healthcare payers (sickness funds). Applications must be submitted separately by every hospital, and NUB funding will only be available to hospitals that negotiate successfully. 

NUB requests can only be made via the InEK data portal.

Within the current application window, the hospitals should submit a NUB application to the InEK and transmit information to the G-BA by October 31, 2025.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.